InvestorsHub Logo
Followers 25
Posts 2345
Boards Moderated 0
Alias Born 06/20/2020

Re: A deleted message

Wednesday, 03/24/2021 3:12:38 PM

Wednesday, March 24, 2021 3:12:38 PM

Post# of 233271

You also need to test for statistical significance and adjust for alpha spend and multiplicity. The 24% improvement is not stat sig in the case of Leronlimab and therefore per the FDA, happened by random chance. I wouldn't expect any longs on this board to understand that because if they did they would have sold.


And if that 24% relative or 9% absolute benefit in a small 62 patient slice of the trial is the best cherry they could pick, just imagine how many warts there are in the rest of the trial. That is why full data will never be released. Just like the M2M full data still hasn't been released. Smoke and mirrors.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News